{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017946","form_type":"8-K","ticker":"ABEO","cik":"0000318306","company_name":"ABEONA THERAPEUTICS INC.","filed_at":"2023-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.779257+00:00","generated_at":"2026-06-14T22:43:54.008917+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Abeona shareholders elect directors, approve 2023 equity plan at annual meeting","bullets":["Michael Amoroso (6.5M for) and Christine Silverstein (6.2M for) elected Class I directors until 2026.","Abeona Therapeutics 2023 Equity Incentive Plan approved: 6.2M for, 569K against, 18K abstentions.","Advisory vote on named executive officer compensation passed: 6.4M for, 282K against, 37K abstentions.","Ratification of Whitley Penn LLP as independent auditor for FY2023 passed: 10.4M for, 49K against, 28K abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017946","json":"https://secwatch.observer/filing/0001493152-23-017946.json","markdown":"https://secwatch.observer/filing/0001493152-23-017946.md","text":"https://secwatch.observer/filing/0001493152-23-017946.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318306/000149315223017946/0001493152-23-017946-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318306/000149315223017946/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T22:43:54.008917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}